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Multiple Factors in Carcinogenesis
by Samuel S. Epstein*
Before making some comments on multiple
factors, I would like briefly to refer to the dis-
cussion at this conference. There has been no
reference, strangely enough, to a law known as
the Delaney Amendment. Asbestos is a car-
cinogen. It is apparently being deliberately add-
ed to certain drugs and foodstuffs by particular
processing and manufacturing practices. Sure-
ly, when asbestos is introduced into foodstuffs
by deliberate processing this is a clear cut con-
travention of the Delaney Amendment. The
whole question of the relevance of the Delaney
Amendment to asbestos in water is a complex
legal matter. Suffice it to say that I think it is
possible to develop a substantive legal argument
that the deliberate discharge of carcinogens
such as asbestos into water represents a con-
travention of the Delaney Amendment.
Now with relation to multiple factors - this
is a fascinating area in which epidemiology has
blazed the trail and toxicology has lagged sadly
behind. I think that with the little we have
heard here on the role of smoking and asbestos,
and from the literature on the subject, it
becomes clear thatsmokingdoes enhance the in-
cidence of bronchogenic cancer following oc-
cupational exposure to asbestos. Similar con-
siderations relate to uranium although,
however, the question of the synergistic orother
positive interactions between smoking and
radon daughters appears somewhat com-
pounded by the fact that silica dust may also be
involved, and thus we appear to have possibly
three factors: smoking, silica dust, and radon
daughters. Now while it is true that
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epidemiology has been particularly helpful in
demonstrating these relationships, there seems
to have been less interest in followingup the im-
plications of such interactions. For instance, it
is possible to postulate one of two entirely
different concepts to account for the synergistic
relationship between smoking and asbestos. One
is an entirely nonspecific mechanism, based on
the concept that smoking has nothing to do with
asbestos and bronchogenic carcinoma except
that it inhibits mucociliary defense
mechanisms; other agents that might inhibit
mucociliary defense mechanisms could probably
also enhance the carcinogenic effects of
asbestos. On the other hand, it is also possible
that there is a very specific mechanism for this
interaction and that the inhaled particles may
interact chemically with certain carcinogens in
cigarette smoke; or the particles may increase
the uptake of carcinogens in cigarette smoke. It
is also possible finally that carcinogens in tobac-
co smoke could sensitize tissues to the car-
cinogenic effect of the foreign particles.
It would appear difficult to differentiate
epidemiologically between the so-called specific
and nonspecific mechanism of smoke-particle
interactions. Now, as I mentioned before, tox-
icology has lagged behind epidemiology in this
area. As you know, forty years ago, Berenblum
and others (1) demonstrated the two-stage
mechanism of skin carcinogenesis in the mouse,
showing that you have an initiating event which
is a specific phenomenon; a very small dose of a
carcinogen could induce sensitization of tissues
to a carcinogenic effect which subsequently can
be unmasked in a relatively nonspecific manner
by a promoting agent. But apart from these ex-
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incidentally as far as I know, cannot be ex-
trapolated to any tissues other than skin, I think
toxicology has played only a small role in
elucidating the whole question of multiple fac-
tors. To a certain extent, this is a reflection of
the simplistic fixation which toxicology has
found itself in as an off-shoot of pharmacology;
it tends to study in a simplistic fashion direct
causal relationships, and in many instances
such studies bear little or no practical
relationship to the realities of life. But that may
be a little uncharitable. Perhaps what is far
more to the point is that the toxicologist can
very simply say, we know how to set up the
tests; do we take a carcinogen which we are in-
terested in studying, then pull 100,000 chemicals
off the shelf and study them one after the other
to see whether there are synergistic interac-
tions?
Clearly this is impractical and clearly perhaps
what toxicology should do is to follow well
behind epidemiology, and when the possibility
of synergistic interactions and multiple factors
is raised, then toxicology should come in and try
to get some impression as to the underlying
basic mechanisms.
The toxicological literature in this area is
pretty skimpy, but let me just mention one or
two illustrations. You are familiar, perhaps,
with the experiments of Sinnhuber, who was in-
terested in finding apparent no-effect levels for
aflatoxins and their induction of liver cancers in
the rat (2). Sinnhuber found that feeding
aflatoxins at levels as low as 0.4 ppb was just
about the lowest level which would induce
cancer of the liver in trout(3). Those who mis-
takenly believe the threshold concept for car-
cinogenesis were eager to seize this as an indica-
tion that levels below 0.4 ppb of aflatoxin were
safe. The absurdity of this viewpoint was well
exemplified by some subsequent studies, in
which Sinhuber mixed the aflatoxin with a very
small amount of hibiscus oil, a naturally oc-
curring product; and instead of having an ap-
parent no-effect level of 0.4 ppb, the apparent
no-effect level reached 0.004 ppb. It is possible,
therefore, to demonstrate massive shifts in ap-
parent no-effect levels by slight modification of
the experimental circumstances. Similarly there
have been other experiments in which benz-
pyrene in trioctanoin has been tested on the skin
of mice and apparent no-effect levels have been
demonstrated. However when the benzpyrene
has been tested in n-dodecane as a solvent, the
apparent no-effect level shifted lower by several
orders of magnitude.
Of interest in the field of particles are three
sets of recent experiments. In the first of these
experiments Saffiotti and his colleagues (5)
were able to demonstrate very simply that when
you put benzpyrene into the lungs of hamsters
by direct endotracheal instillation, you don't get
tumors; when you put iron particles into the
lungs of hamsters by direct endotracheal in-
stillation, you don't get tumors; but when you
put mixtures of benzpyrene and iron oxide into
the lungs of hamsters, you get a high incidence
of bronchogenic squamous carcinomas. This is a
clear indication of an interaction between par-
ticles and carcinogens. Again, one can say
basically, it may well be a nonspecific effect, the
iron merely holds the benzpyrene in place or
prevents it being leached out rapidly and I think
one can question exactly what the mechanisms
are here. Perhaps an even more interesting ex-
periment of Saffiotti was that which he did with
Montesano (6) which I would strongly recom-
mend you to consider deeply the implications if
you are ever tempted to talk about apparent no-
effect levels of carcinogens. Saffiotti took baby
hamsters and primed them at birth with very
low levels of dimethylnitrosamine or
diethylnitrosamine (in the microgram range).
Nothing happened to them: they grew beautiful-
ly and showed no sign of illness, no sign of
sickness, no sign of tumors. Again one can say,
here is a no-effect level of nitrosamines.
However, if you take these hamsters which have
primed at birth with very low levels of
nitrosamines and when they reach adult life,
you insufflate through their tracheas small
levels ofiron dust in the absence ofacarcinogen,
you will induce a high incidence of lower
respiratory tract tumors. In other words, a
small dose of a carcinogen at birth followed by
the nonspecific presence of particles in the
lungs of hamsters induces a high incidence of
lower respiratory tract tumors.
Sid Laskin is here and I hesitate to talk about
his work in front of him, but his work is so
fascinating that let me just mention it briefly.
Laskin's group (7) have been doing some very
elegant studies in which they have been expos-
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benzpyrene alone in aerosols. Animals exposed
to sulfur dioxide alone or to benzpyrene alone to
all intents and purposes get no bronchial car-
cinomas; however, if you expose rats to both
benzpyrene and to sulfur dioxide, you get
squamous bronchial cancers in the rats, and
some squamous carcinomas of the forestomach.
What does all this mean in relation to asbestos?
When you load tissues and organs with asbestos
what will this do to the ability ofthese organs to
take up carcinogens from blood or from other
tissues? In other words, load the tissues with
asbestos and find what happens to the uptake
and metabolism of other carcinogens such as
N-nitroso compounds, also see what happens to
the ability of alkylating agents or nitrosamines
to alkylate DNA. What happens if you have
asbestos present in tissues? Will this modify the
alkylation of DNA by nitroso compunds or not?
Similarly, can one demonstrate possible
chemical interactions between other car-
cinogens and asbestos eitherinvitro andinvivo.
Can the presence of asbestos in tissues increase
the carcinogenic activity of other carcinogens?
If, for instance, you have a carcinogen that is
normally organotropic for the liver, and you
load the pancreas of workers exposed oc-
cupationally to asbestos with this carcinogen,
will you create a different pattern of
organotropism? And again, can particles sen-
sitize tissues to the activity of chemical car-
cinogens? Over and above natural
organotropism, can you modify the incidence of
the effect of a carcinogen by the presence of
asbestos? Similarly, can chemicals sensitize
tissues to the carcinogenic activity of asbestos?
These are questions to ask. I would venture to
suggest that from an experimental standpoint
there are no overwhelming difficulties in doing
such studies and attempting to get such
answers. I think that if we were able to get in-
formation of this kind we could to a certain ex-
tent begin to start complementing the massive
quality and quantity of epidemiological data
that has already developed on the role of multi-
ple factors of asbestos carcinogenesis.
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